Table 3.
n | Moderate-to-Vigorous Intensity PA (Minutes/Week) |
Meeting AET Guidelines | Meeting RET Guidelines | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | SD | Difference | 95% CI | p | n | % | p | n | % | p | ||
Overall | 72 | 142.4 | 263.1 | 27 | 38 | 7 | 10 | |||||
Subgroups’ | ||||||||||||
Age | ||||||||||||
≤66.5 years | 34 | 119.9 | 168.7 | −61.8 | −191.9 to 68.3 | 0.35 | 14 | 21 | 0.08 | 4 | 6 | 1.0 |
>66.5 years | 34 | 181.6 | 340.4 | 13 | 19 | 3 | 4 | |||||
Income | ||||||||||||
<$40,000/year | 26 | 156.0 | 345.7 | 1.7 | −137.9 to 141.3 | 0.98 | 8 | 12 | 0.22 | 3 | 5 | 1.0 |
≥$40,000/year | 39 | 154.2 | 218.1 | 18 | 28 | 4 | 6 | |||||
Exercise Limitations | ||||||||||||
≤2 limitations | 42 | 159.3 | 190.9 | 40.6 | −85.3 to 166.6 | 0.52 | 20 | 28 | 0.04 1 | 5 | 7 | 0.69 |
>2 limitations | 30 | 118.7 | 342.0 | 7 | 10 | 2 | 3 | |||||
Medication Use | ||||||||||||
≤2 medications | 50 | 162.4 | 209.1 | 65.6 | −68.7 to 199.9 | 0.33 | 24 | 33 | 0.008 | 6 | 8 | 0.63 |
>2 medications | 22 | 96.8 | 359.0 | 3 | 4 | 1 | 1 | |||||
Fatigue Score (/10) | ||||||||||||
0–2 | 20 | 190.3 | 189.5 | 26.8 | −142.0 to 195.6 | 0.23 2 | 13 | 18 | 0.015 | 3 | 4 | 0.30 |
3–5 | 33 | 163.5 | 344.9 | 108.2 | −56.0 to 272.4 | 9 | 13 | 4 | 6 | |||
6–10 | 19 | 55.3 | 110.6 | 5 | 7 | 0 | 0 | |||||
Cancer Diagnosis | ||||||||||||
Breast cancer | 35 | 134.3 | 216.8 | −15.7 | −108.8 to 140.3 | 0.80 | 13 | 18 | 0.95 | 3 | 4 | 1.0 |
Other cancers | 37 | 150.0 | 303.3 | 14 | 19 | 4 | 6 | |||||
Cancer Stage | ||||||||||||
Local (Stages I–III) | 45 | 180.7 | 303.7 | 94.8 | −39.1 to 228.8 | 0.16 | 22 | 32 | 0.02 | 6 | 9 | 0.41 |
Metastatic (Stage IV) | 24 | 85.8 | 170.0 | 5 | 7 | 1 | 1 | |||||
Cancer Side Effects | ||||||||||||
≤2 side effects | 42 | 135.7 | 204.5 | −16.0 | −142.2 to 110.3 | 0.80 | 17 | 24 | 0.54 | 7 | 10 | 0.04 |
>2 side effects | 30 | 151.7 | 332.0 | 10 | 14 | 0 | ||||||
Perceived Exercise Benefit:
General Health |
||||||||||||
No/Unsure | 30 | 148.3 | 335.6 | −0.4 | −130.8 to 130.0 | 1.0 | 9 | 13 | 0.17 | 3 | 4 | 1.0 |
Yes | 39 | 148.7 | 204.2 | 18 | 26 | 4 | 6 | |||||
Perceived Exercise Benefit:
Cancer-Related |
||||||||||||
No | 20 | 194.0 | 396.4 | 75.9 | −85.3 to 237.2 | 0.35 | 7 | 13 | 0.90 | 2 | 4 | 1.0 |
Yes | 36 | 118.1 | 207.5 | 12 | 21 | 4 | 7 | |||||
Current PA Goals | ||||||||||||
No Increase in PA | 25 | 204.8 | 354.7 | 86.9 | −48.9 to 222.7 | 0.21 | 12 | 18 | 0.23 | 4 | 6 | 0.41 |
Increase in PA | 42 | 117.9 | 203.0 | 14 | 21 | 3 | 4 | |||||
Current Exercise Motivators | ||||||||||||
≤3 motivators | 39 | 118.9 | 291.4 | −51.3 | −175.7 to 73.0 | 0.41 | 11 | 15 | 0.08 | 2 | 3 | 0.24 |
>3 motivators | 33 | 170.2 | 226.4 | 16 | 22 | 5 | 7 | |||||
Exercise Facilitating Factors | ||||||||||||
≤1 facilitator required | 43 | 141.6 | 292.6 | −1.8 | −128.8 to 125.2 | 0.98 | 15 | 21 | 0.58 | 3 | 4 | 0.43 |
>1 facilitator required | 29 | 143.5 | 217.0 | 12 | 17 | 4 | 6 | |||||
Interest in Community Exercise Program | ||||||||||||
No/Unsure | 31 | 150.2 | 321.7 | 2.9 | −127.1 to 132.9 | 0.96 | 10 | 14 | 0.29 | 4 | 6 | 0.69 |
Yes | 38 | 147.2 | 217.3 | 17 | 25 | 3 | 4 |
1 Bolded values represent significant differences between subgroups; 2 Comparison between all three groups using one-way ANOVA.